期刊文献+

原发性高血压病人血浆中HCY、ADM和CGRP浓度测定的意义 被引量:9

Changes in Plasma HCY,ADM and CGRP in Patients with Essential Hypertension and Their Roles in Its Pathogenesis
下载PDF
导出
摘要 目的通过测定原发性高血压病人血浆同型半胱氨酸(homocysteine HCY)、肾上腺髓质素(adrenomedullin ADM)、降钙素基因相关肽(CGRP)活性物质的水平,探讨血管活性物质与原发性高血压的关系,为原发性高血压的预防和治疗提供理论依据。方法随机选取未经治疗的原发性高血压病人42例作为研究组,按高血压分级标准分为3个亚组,,对照组选择20例同期健康体检的正常人。采受试者空腹静脉血,用荧光法定量检测HCY,用放射免疫法检测ADM和CGRP。结果(1)研究组血浆HCY、ADM浓度明显高于对照组,而CGRP水平明显下降,有显著统计学差异(P均<0.01)。(2)研究组三个亚组1级组、2级组和3级组HCY、ADM水平随着血压升高而升高,组间差别有统计学意义(P<0.01)。(3)研究组血浆HCY与ADM浓度呈正相关(r=0.941,P<0.01),与CGRP呈负相关(r=-0.480,P<0.01)。结论研究组血浆HCY、ADM水平明显升高,且血压越高,浓度越高,而CGRP水平随着血压的升高却明显降低;研究组HCY、CGRP水平变化,提示它们参与了高血压的发生与发展;ADM继发性升高,可阻止高血压进一步发展,对机体具有保护作用。 Objective To detect the levels of plasma homocysteine (HCY), adrenomedullin (ADM), calcitonin gene-related peptide (CGRP) in essential hypertension (EH) patients, investigate whether they are involved in the pathogenesis of EH, and provide the theoretic basis for its prevention. Methods A total of 42 EH patients without taking medication were randomly enrolled in study group which was divided into three subgroups, and another 20 healthy volunteers were enrolled in control group. The level d plasma HCY was measured by means of fluorometric method while the levels of ADM and CGRP were determined by radioimmunoassay. Results ( 1 ) The levels of plasma HCY and ADM in the study group were higher than those of the control group, whereas the level of plasma CGRP was lower ( P 〈 0.01 ). (2) The levels of HCY and ADM in class I, class II and class III subgroups increased along with the ascension of the blood.pressure, and there were statistical differences between any two of the subgroups (P 〈 0.01 ). ( 3 ) In the study group plasma HCY was positively correlated with ADM ( r = 0. 941, P 〈 0.01 ), but negatively correlated with CGRP ( r = - 0.480, P 〈 0.01 ). Conclusion In Eli patients, the concentrations of plasma HCY and ADM increase and are positively correlated with the level of blood pressure; the concentration of plasma CGRP decreases and is negatively correlated with the level of blood pressure. The changes in plasma HCY and CGRP level in EH patients suggest that they are involved in the pathogenesis and the development of hypertension. The secondary advance of ADM can inhibit the growth of hypertension and provide a protective effect on their bodies.
出处 《临床军医杂志》 CAS 2008年第1期24-26,共3页 Clinical Journal of Medical Officers
关键词 原发性高血压 同型半胱氨酸 肾上腺髓质素 降钙素基因相关肽 hypertension homocysteine adrenomedullin calcitonin gene-related peptide
  • 相关文献

参考文献6

  • 1唐朝枢,齐永芬.血管活性肽与微循环[J].微循环学杂志,2004,14(3):1-4. 被引量:7
  • 2Lentz S R. Homocysteine and vascular dysfunction[J].Rev Life Sci,1997,6:1205.
  • 3Stein J H,Mcbride P E.Hyperhomocysteinmia and atherosclerotic vascular disease[J].Arch Intern Med.1998,158:1301-1306.
  • 4Kohno M,Yokokawa K,Yasunari K, et al. Induction by lysophosphosphatidylcholine,a major phospholipid component of atherogenic lipoproteins, of human coronary artery smooth muscle cell migration[J]. Circulation,1998,98(4):353-359.
  • 5Kohno M, Yokokawa K, Kano H, et al. Adrenomedullin is a potent inhibator of angiotensin Ⅱ induced migration of human coronary artery smooth muscle cells[J]. Hypertension,1997,29(6):1309-1313.
  • 6Suan C,Louis M,Fouseca V.Hyperhomocysteinemia:Anemerging and important risk factor for thromboembolic and cardiovascular disease[J].Clin chem,1996,106:709-722.

二级参考文献13

  • 1Vulpis V. Endothelin, microcirculation and hemorheology. Clin Hemorheol Microcirc,1999,21(3-4):273~276.
  • 2Hinson JP, Kapas S, Smith DM. Adrenomedullin, a multifunctional regulatory peptide. Endocrine Review, 2000, 21(2):138~167.
  • 3Henrion D, Kubis N, Levy BI. Physiological and pathophysiological functions of the AT(2) subtype receptor of angiotensin II: from large arteries to the microcirculation. Hypertension,2001,38(5):1 150~1 157.
  • 4Maguire JJ. Discovering orphan receptor function using human in vitro pharmacology. Curr Opin Pharmacol,2003,3(2):135~139.
  • 5Howard A D, McAllister G, Feighner S D, et al. Orphan G-protein-coupled receptors and natural ligand discovery. Trends in Pharmacological Science, 2001,22(3):132~140.
  • 6Chu DQ, Smith DM, Brain SD. Studies of the microvascular effects of adrenomedullin and related peptides. Peptides,2001,22(11):1 881~1 886.
  • 7Nikitenko LL, Smith DM, Bicknell R,et al. Transcriptional regulation of the CRLR gene in human microvascular endothelial cells by hypoxia.FASEB J,2003,17(11):1 499~1 501.
  • 8Brain SD, Chu DQ. Effect of CGRP and related peptides in the microcirculation. Scientific World Journal,2001,1(12 Suppl 1):34.
  • 9汤健.生物活性蛋白的功能多样性与分子内调控[J].中华医学杂志,2000,80(10):727-728. 被引量:12
  • 10齐永芬,唐朝枢.降钙素基因相关肽家族的受体活性修饰蛋白[J].生理科学进展,2001,32(3):251-253. 被引量:11

共引文献6

同被引文献62

引证文献9

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部